MicroRNA‐200b is a potential biomarker of the expression of PD‐L1 in patients with lung cancer

BACKGROUND: Advanced non‐small cell lung cancer (NSCLC) has a high mortality rate and poor prognosis. However, outcomes have gradually improved after the introduction of novel immunotherapies, including immune checkpoint inhibitors (ICIs). Although programmed death‐ligand 1 (PD‐L1) expression in tum...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Thorac Cancer
Main Authors: Katakura, Seigo, Kobayashi, Nobuaki, Hashimoto, Hisashi, Kamimaki, Chisato, Tanaka, Katsushi, Kubo, Sousuke, Nakashima, Kentaro, Teranishi, Shuhei, Manabe, Saki, Watanabe, Keisuke, Horita, Nobuyuki, Hara, Yu, Yamamoto, Masaki, Kudo, Makoto, Piao, Hongmei, Kaneko, Takeshi
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons Australia, Ltd 2020
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7529545/
https://ncbi.nlm.nih.gov/pubmed/32893980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13653
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados